Trials with mice were conducted by researchers who injected a specific antibody fragment against soluble aggregates of the A peptide, responsible for the toxicity and cell death characteristic of Alzheimer's Disease. The beneficial effects were seen at the behavioural, cellular and molecular levels five days after an intraperitoneal dose was administered. Since the first case of Alzheimer's disease was described, the disease has been associated with ...
Read More
No comments:
Post a Comment